EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Plasma p‐tau217 Versus p‐tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease‐Related Neurostructural Changes and Cognitive Function

Eleonora Fiorenzato, Simone Cauzzo, Giulia Musso, Roberta Biundo, Chiara Ceolin, Chiara Cosma, Carmelo Alessandro Fogliano, Wassilios G. Meissner, Valentina Misenti, Stefania Moz, Maria Laura Nasi, Francesca Vianello, Renzo Manara, Martina Montagnana, Giuseppe Sergi, Angelo Antonini

Movement Disorders · 2026-06-15

DOI: 10.1002/mds.70392 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Plasma phosphorylated‐tau at threonine‐217 (p‐tau217) and threonine‐181 (p‐tau181) are scalable, minimally invasive biomarkers of Alzheimer's disease (AD) pathology. In Parkinson's disease (PD), AD co‐pathology may contribute to its clinical heterogeneity. However, the existing literature has predominantly focused on p‐tau181, with comparatively limited investigation of p‐tau217. Objective The aim is to evaluate plasma p‐tau217 and p‐tau181 as biomarkers of AD co‐pathology across the PD cognitive spectrum, relative to a cohort of dementia‐free older adults. Methods Plasma p‐tau217 and p‐tau181 were measured in 70 PD patients and 83 older adults. Associations with cognitive impairment, disease severity (Hoehn‐and‐Yahr), and neurostructural measures—including global atrophy, hippocampal volume, and a magnetic resonance imaging‐based AD signature—were assessed using correlation and dominance analyses. Results Both p‐tau217 and 181 were higher in PD with cognitive impairment and dementia compared with cognitively normal PD. P‐tau217 showed stronger associations than p‐tau181 with AD‐like neurostructural changes, multidomain cognitive deficits, greater disease severity, and reduced functional independence. Conclusions Plasma p‐tau217 and p‐tau181 may serve as scalable markers of AD‐related processes associated with neurostructural, clinical, and cognitive outcomes in PD. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →